Investor

UT Horizon Fund

Last cheque observed Jun 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series ASeedSeries CPharmaceutical

Cheques on record
0%of best year0cheques in 12 months, 22 on record
Since the last cheque4142days00hrs00min00sec
Median round$5.2MRounds led0 of 22Sole investor12 roundsMostly inUnited States, 100%
Pitch UT Horizon Fund

UT Horizon Fund highlights

  1. 01

    22 rounds on record

  2. 02

    Mostly Series A and Seed: 53% of its rounds

  3. 03

    Sole investor in 12 rounds, median $3.9M

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Pharmaceutical
Cold pitches
Not stated

The record

Every round we can evidence, newest first22 appearances

  1. 2015

    4 rounds

  2. Jun
    Admittance TechnologiesVenture · US$3.9MSole investor
  3. May
    Decisio HealthUSUndisclosedSole investor
  4. Mar
    Aeglea BioTherapeuticsSeries B · US$44MWith 4 others
  5. Feb
    M87Series B · US$3.0MWith 1 other
  6. 2014

    5 rounds

  7. Sept
    Lung TherapeuticsSeries A · US$1.6MSole investor
  8. Aug
    Apollo EndosurgerySeries C · US$61MSole investor
  9. Jul
    Molecular MatchSeries AUndisclosedWith 1 other
  10. Apr
    M87Series A · US$3.0MWith 2 others
  11. Jan
    Aeglea BioTherapeuticsSeries A · US$12MWith 5 others
  12. 2013

    9 rounds

  13. Oct
    Lynx LaboratoriesSeed · USUndisclosedWith 2 others
  14. Sept
    EMIT CorporationSeries AUndisclosedSole investor
  15. Sept
    MicroTransponderSeed · US · finsmes.com$3.4MWith 2 others
  16. Jul
    Rapamycin HoldingsDebt · US · sec.gov$616KSole investor
  17. Jul
    Lung TherapeuticsUSUndisclosedSole investor
  18. Mar
    PLx PharmaVenture · US · sec.gov$8.3MWith 2 others
  19. Feb
    FibeRioSeries C · US · finsmes.com$13MWith 4 others
  20. Jan
    M87USUndisclosedSole investor
  21. Jan
    CardiovateSeedUndisclosedSole investor
  22. 2012

    3 rounds

  23. Dec
    Rapamycin HoldingsSeed · USUndisclosedWith 1 other
  24. Oct
    latakooUS$550KSole investor
  25. Feb
    Apollo EndosurgeryVenture · US · statesman.com$48MSole investor
  26. 2011

    1 round

  27. Dec
    Cerevast TherapeuticsSeries C · US · sec.gov$6.6MSole investor

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Who they invest alongside

The investors most often in the same rounds as UT Horizon Fund. A count of rooms they were both in, not a relationship either has claimed.

Lilly VenturesGrowth equity2rounds togetherNovartis Venture FundCorporate VC2rounds together

Quick answers about UT Horizon Fund

What does UT Horizon Fund invest in?

UT Horizon Fund invests most often at Series A and Seed (53% of the rounds on record), in sectors such as Pharmaceutical.

How active is UT Horizon Fund?

22 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2015.

How big are UT Horizon Fund's cheques?

The median round it joins is $5.2M.

Does UT Horizon Fund lead rounds?

Rarely, if at all: none of its 22 investments on record names it as the lead.

Where does UT Horizon Fund invest?

Most of the companies it backs are in the United States (100%).

Is UT Horizon Fund investing now?

No investments in the last 12 months; the latest was in Jun 2015.

Who does UT Horizon Fund invest alongside?

Most often Lilly Ventures (2 rounds together) and Novartis Venture Fund (2 rounds together).

What kind of investor is UT Horizon Fund?

UT Horizon Fund is a VC firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it